Abstract
Application of repetitive transcranial magnetic stimulation was effective and safe in treating a 55-year-old man with comorbid depression and panic disorder, which occurred 6 months after a myocardial infarction.
MeSH terms
-
Anti-Anxiety Agents / therapeutic use
-
Antidepressive Agents, Second-Generation / therapeutic use
-
Citalopram / therapeutic use
-
Clorazepate Dipotassium / therapeutic use
-
Cyclohexanols / therapeutic use
-
Depressive Disorder / complications*
-
Depressive Disorder / etiology
-
Depressive Disorder / therapy*
-
Humans
-
Male
-
Middle Aged
-
Myocardial Infarction / complications*
-
Myocardial Infarction / psychology*
-
Panic Disorder / complications*
-
Panic Disorder / etiology
-
Panic Disorder / therapy*
-
Psychiatric Status Rating Scales
-
Transcranial Magnetic Stimulation*
-
Venlafaxine Hydrochloride
Substances
-
Anti-Anxiety Agents
-
Antidepressive Agents, Second-Generation
-
Cyclohexanols
-
Citalopram
-
Clorazepate Dipotassium
-
Venlafaxine Hydrochloride